GB9921062D0 - Use of cholestrol-lowering agent - Google Patents

Use of cholestrol-lowering agent

Info

Publication number
GB9921062D0
GB9921062D0 GBGB9921062.7A GB9921062A GB9921062D0 GB 9921062 D0 GB9921062 D0 GB 9921062D0 GB 9921062 A GB9921062 A GB 9921062A GB 9921062 D0 GB9921062 D0 GB 9921062D0
Authority
GB
United Kingdom
Prior art keywords
cholestrol
lowering agent
lowering
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9921062.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Priority to GBGB9921062.7A priority Critical patent/GB9921062D0/en
Publication of GB9921062D0 publication Critical patent/GB9921062D0/en
Priority to ARP000100408A priority patent/AR022462A1/en
Priority to JP2000596939A priority patent/JP2002536333A/en
Priority to PL00349137A priority patent/PL349137A1/en
Priority to CZ20012631A priority patent/CZ20012631A3/en
Priority to IDW00200101666A priority patent/ID30131A/en
Priority to BR0007991-0A priority patent/BR0007991A/en
Priority to EP00901748A priority patent/EP1150679A1/en
Priority to HU0105019A priority patent/HUP0105019A3/en
Priority to PCT/GB2000/000285 priority patent/WO2000045819A1/en
Priority to CN00803519A priority patent/CN1347320A/en
Priority to IL14466200A priority patent/IL144662A0/en
Priority to CA002358641A priority patent/CA2358641A1/en
Priority to NZ512681A priority patent/NZ512681A/en
Priority to SK1111-2001A priority patent/SK11112001A3/en
Priority to AU23051/00A priority patent/AU769897B2/en
Priority to KR1020017009822A priority patent/KR100699287B1/en
Priority to TR2001/02236T priority patent/TR200102236T2/en
Priority to EEP200100404A priority patent/EE04659B1/en
Priority to MYPI20000415A priority patent/MY136382A/en
Priority to IS5996A priority patent/IS5996A/en
Priority to NO20013810A priority patent/NO319827B1/en
Priority to HK02102713.0A priority patent/HK1040924A1/en
Priority to JP2011035406A priority patent/JP2011137023A/en
Ceased legal-status Critical Current

Links

GBGB9921062.7A 1999-02-06 1999-09-08 Use of cholestrol-lowering agent Ceased GB9921062D0 (en)

Priority Applications (24)

Application Number Priority Date Filing Date Title
GBGB9921062.7A GB9921062D0 (en) 1999-09-08 1999-09-08 Use of cholestrol-lowering agent
ARP000100408A AR022462A1 (en) 1999-02-06 2000-01-31 USE OF AN AGENT THAT DECREASES CHOLESTEROL
EEP200100404A EE04659B1 (en) 1999-02-06 2000-02-01 Use of a cholesterol lowering agent
CN00803519A CN1347320A (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
NZ512681A NZ512681A (en) 1999-02-06 2000-02-01 Use of (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulphonyl)amino]pyrimidin-5-yl]-(3R,5S)-3,5- dihydroxyhept-6-enoic acid as a cholesterol-lowering agent
CZ20012631A CZ20012631A3 (en) 1999-02-06 2000-02-01 Use of cholesterol level reducing preparation
IDW00200101666A ID30131A (en) 1999-02-06 2000-02-01 USE OF CHOLESTEROL
BR0007991-0A BR0007991A (en) 1999-02-06 2000-02-01 Use of the compound (e) -7- [4- (4-fluorophenyl) -6-isopropyl-2- [methyl (methylsulfonyl) amino] pyrimidin -5-yl] - (3r, 5s) -3,5-dihydroxiept -6-enoic, or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods of preparing a pharmaceutical composition, reducing the levels of c-ldl and the lipid ratio of c-ldl / c-hdl, and, regimen dosage
EP00901748A EP1150679A1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
HU0105019A HUP0105019A3 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
PCT/GB2000/000285 WO2000045819A1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
JP2000596939A JP2002536333A (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering drugs
IL14466200A IL144662A0 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
CA002358641A CA2358641A1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
PL00349137A PL349137A1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
SK1111-2001A SK11112001A3 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
AU23051/00A AU769897B2 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
KR1020017009822A KR100699287B1 (en) 1999-02-06 2000-02-01 Use of cholesterol-lowering agent
TR2001/02236T TR200102236T2 (en) 1999-02-06 2000-02-01 The use of cholesterol-lowering agent.
MYPI20000415A MY136382A (en) 1999-02-06 2000-02-04 Use of cholesterol-lowering agent
IS5996A IS5996A (en) 1999-02-06 2001-07-10 Use of cholesterol-lowering agent
NO20013810A NO319827B1 (en) 1999-02-06 2001-08-03 Use of cholesterol-lowering agent and method of preparation thereof, as well as pharmaceutical composition
HK02102713.0A HK1040924A1 (en) 1999-02-06 2002-04-10 Use of cholesterol-lowering agent
JP2011035406A JP2011137023A (en) 1999-02-06 2011-02-22 Use of cholesterol-lowering agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9921062.7A GB9921062D0 (en) 1999-09-08 1999-09-08 Use of cholestrol-lowering agent

Publications (1)

Publication Number Publication Date
GB9921062D0 true GB9921062D0 (en) 1999-11-10

Family

ID=10860455

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9921062.7A Ceased GB9921062D0 (en) 1999-02-06 1999-09-08 Use of cholestrol-lowering agent

Country Status (1)

Country Link
GB (1) GB9921062D0 (en)

Similar Documents

Publication Publication Date Title
HUP0202477A3 (en) Use of phthalazine derivatives
HUP0200736A2 (en) Liquid compositions comprising skin benefit agent
PL355101A1 (en) Use of h1
GB9915414D0 (en) Medical use
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
EP1163852A4 (en) Masking agent
GB9913536D0 (en) Use
IL145995A0 (en) Use
GB9900227D0 (en) Use of a composition
IL147891A0 (en) Topical use of anti-muscarnic agents
PL339848A1 (en) Therapeutic agent against hypephosphataemia
HK1047241A1 (en) Radioprotecting agent
PL349137A1 (en) Use of cholesterol-lowering agent
GB9907965D0 (en) Medical use
EP1218407A4 (en) Uses of kappa-conotoxin pviia
GB0030067D0 (en) Therapeutic agent
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
PL350963A1 (en) Use of arylalkanoylpyridazines
GB9927927D0 (en) Compound composition and use
GB9925379D0 (en) Medical use
GB9919971D0 (en) Use
GB9921062D0 (en) Use of cholestrol-lowering agent
GB9929772D0 (en) New use
GB9906124D0 (en) Therapeutic agent
GB9911238D0 (en) Therapeutic use

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)